For researchers planning a fat-loss study in 2026, the strongest candidates are retatrutide, semaglutide, tirzepatide, AOD9604, and lipotropic compounds â each acting through a different mechanism. This guide ranks them by research evidence, explains the mechanism behind each, and maps them to assay panels so you can pick the peptide (or combination) that fits your […]
Monthly Archives: November 2026
For researchers planning to buy BPC-157 in 2026, the short answer is: buy only from a supplier that publishes a certificate of analysis (COA) with HPLC purity data, provides third-party lab results, shows transparent company details, and clearly labels the product for laboratory research only. This guide explains how to evaluate a BPC-157 source, what […]
Buying BPC-157 online for research comes down to documentation: batch-specific CoA, HPLC purity (typically ≥98%), correct 15-amino-acid identity, and a supplier that labels the product research-only. BPC-157 is a stable gastric pentadecapeptide used in animal healing and gastrointestinal studies, and the buying process should be identical to other research peptides: verify before you pay. How […]
Reconstituting BPC-157 is a three-step protocol: add bacteriostatic water to the lyophilised vial, swirl gently until fully dissolved, and store the working solution at 2–8 °C. Concentration math (peptide mass ÷ solvent volume) determines injection volumes, and batch-matched documentation matters because BPC-157’s 15-amino-acid structure is sensitive to vigorous shaking and freeze-thaw cycles. What You Need […]
BPC-157 dosing in published rat studies is typically expressed per kilogram — commonly around 10 µg/kg given orally or by injection — with some protocols using fixed doses of 200–300 µg per animal. BPC-157 (body protection compound) is a stable gastric pentadecapeptide studied mainly for gastrointestinal protection and soft-tissue healing in animal models, and research […]
Retatrutide dosing in phase 2 research was once weekly with stepwise escalation from 2 mg to maintenance doses of 4, 8 or 12 mg, with the 12 mg arm producing the largest effects (~24% mean weight reduction at 48 weeks). Dose-dependent gastrointestinal events make slow titration the standard protocol design. Dosing in the Phase 2 […]
Retatrutide’s mechanism of action is balanced agonism of three receptors — GIP, GLP-1 and glucagon — which distinguishes it from dual-agonist incretin peptides and is hypothesised to drive greater weight loss by combining appetite suppression with increased energy expenditure. Phase 2 data (Jastreboff et al., NEJM, 2023) reported a mean weight reduction of about 24% […]
Buying tirzepatide peptide for research starts with vial specs and purity documentation: confirm the vial strength, verify HPLC purity (typically ≥98%), and match the batch number on the certificate of analysis to the vial label before purchase. Tirzepatide is supplied as lyophilised 5, 10 and 15 mg research vials that are reconstituted with bacteriostatic water […]
Tirzepatide dosage in published research is once weekly, starting at 2.5 mg and titrating in 2.5 mg steps to a maintenance dose of 5, 10 or 15 mg. In the SURPASS programme, weekly doses of 5–15 mg produced dose-dependent HbA1c and weight reductions, with the largest effects at 15 mg; titration in 2.5 mg increments […]
Buying semaglutide online for research use starts with a document check, not a price check: the batch’s certificate of analysis (CoA), HPLC purity (typically ≥98%), batch traceability and a clear research-only statement. A reliable research supplier makes all four verifiable before shipment, and treats purity data as part of the product rather than an optional […]
